|
Iniesta-Navalón C, Urbieta-Sanz E, Gascón-Cánovas JJ, Rentero-Redondo L, Cabello Muriel A, García-Molina C. [Risk prescription associated to treatment at home of the elderly patient when admitted to the hospital]. Farm Hosp. 2013 Mar-Apr;37(2):156-60. doi: 10.7399/FH.2013.37.2.461. Spanish. PubMed PMID: 23789760.
AÑO: 2013
|
23789760
|
Cabello-Muriel A, Urbieta-Sanz E, Iniesta-Navalón C, García-Molina C, Rentero-Redondo L, Antequera-Lardón T. [Follow-up of analytical parameters in Internal Medicine patients to detect adverse events]. Farm Hosp. 2013 Jan-Feb;37(1):35-40. doi: 10.7399/FH.2013.37.1.59. Spanish. PubMed PMID: 23461498.
AÑO: 2013
|
|
Iniesta Navalón C, Urbieta Sanz E, Gascón Cánovas JJ, Madrigal de Torres M. [Inadequate prescription of drugs in the elderly]. Rev Clin Esp. 2012 May;212(5):268-70. doi: 10.1016/j.rce.2011.11.009. Epub 2012 Jan 20. Spanish. PubMed PMID: 22264770.
AÑO: 2012; IF: 1.304
|
|
Diaz LS, Navalon CI, Espin RG, Prado IN, Redondo LR. Impact of proactive of infliximab monitoring using the Bayesian approach in the maintenance phase in patients with inflammatory bowel disease. Gastroenterol Hepatol. 2023 Aug-Sep;46(7):504-511. doi: 10.1016/j.gastrohep.2022.10.019. Epub 2022 Nov 15. English, Spanish. PubMed PMID: 36400260.
AÑO: 2023; IF: 2.2
|
|
Iniesta-Navalon C, Rios-Saorin M, Rentero-Redondo L, Anez-Castano R, Urbieta-Sanz E. Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients. Gastroenterol Hepatol. 2024 Oct 21:S0210-5705(24)00284-X. doi: 10.1016/j.gastrohep.2024.502277. Online ahead of print. English, Spanish. PubMed PMID: 39442691.
AÑO: 2024; IF: 2.2
|